Published in Appl Ergon on June 01, 1994
Static Anthropometric Characteristics of Bangladeshi Vehicle Driver: A Case Study. Scientifica (Cairo) (2016) 0.75
Wildtype Kras2 can inhibit lung carcinogenesis in mice. Nat Genet (2001) 3.27
A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet (2004) 3.05
Ossifying fibromas of the jaw bone: 20 cases. Dentomaxillofac Radiol (2010) 2.15
Establishment and characterization of SV40 T-antigen immortalized human esophageal epithelial cells. Cancer Res (1991) 1.88
Arginine deprivation as a targeted therapy for cancer. Curr Pharm Des (2008) 1.82
Risk of miscarriage and a common variant of the estrogen receptor gene. Am J Epidemiol (1993) 1.39
Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes. Cancer Res (1997) 1.36
Gene expression signatures identify novel regulatory pathways during murine lung development: implications for lung tumorigenesis. J Med Genet (2003) 1.31
Identification of candidate lung cancer susceptibility genes in mouse using oligonucleotide arrays. J Med Genet (2002) 1.23
Arginine deprivation, autophagy, apoptosis (AAA) for the treatment of melanoma. Curr Mol Med (2010) 1.21
Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis. Blood (1998) 1.18
Activation of mitogen-activated protein (MAP) kinase pathway by pervanadate, a potent inhibitor of tyrosine phosphatases. J Biol Chem (1996) 1.14
A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin. Cancer Res (2000) 1.07
Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase. Br J Cancer (2012) 1.06
An additional 136 SSLP markers typed for the AXB and BXA recombinant inbred mouse strains. Mamm Genome (1997) 1.04
Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene. Exp Lung Res (1998) 1.03
Alternative splicing of the K-ras gene in mouse tissues and cell lines. Exp Lung Res (2001) 1.02
Cancer chemopreventive activity of brassinin, a phytoalexin from cabbage. Carcinogenesis (1995) 1.02
Heavy metal contamination and distribution in the urban environment of Guangzhou, SE China. Environ Geochem Health (2006) 1.01
The second intron of the K-ras gene contains regulatory elements associated with mouse lung tumor susceptibility. Proc Natl Acad Sci U S A (1994) 1.00
Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine. Cancer Res (1990) 1.00
Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype. Cancer Res (2001) 1.00
Role of proto-oncogene activation in carcinogenesis. Environ Health Perspect (1992) 0.99
At least four loci and gender are associated with susceptibility to the chemical induction of lung adenomas in A/J x BALB/c mice. Genomics (1998) 0.98
The suppression of SH3BGRL is important for v-Rel-mediated transformation. Oncogene (2006) 0.98
Modulation of the multidrug-resistance phenotype by new tropane alkaloid aromatic esters from Erythroxylum pervillei. J Nat Prod (2001) 0.95
Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors. Carcinogenesis (1993) 0.94
A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice. Oncogene (2006) 0.91
Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-alpha and p16INK4a-beta in mouse lung tumor cells. Oncogene (1996) 0.90
5-Aza-2'-deoxycytidine is chemopreventive in a 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone-induced primary mouse lung tumor model. Carcinogenesis (1999) 0.90
Single nucleotide polymorphism (SNP) analysis of mouse quantitative trait loci for identification of candidate genes. J Med Genet (2004) 0.89
K-ras mutations in lung tumors from A/J and A/J x TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate. Carcinogenesis (1995) 0.88
Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis. Exp Lung Res (2000) 0.88
Inactivation of both Rb and p53 pathways in mouse lung epithelial cell lines. Exp Lung Res (2001) 0.88
Entropy and distance of random graphs with application to structural pattern recognition. IEEE Trans Pattern Anal Mach Intell (1985) 0.87
Deletion mapping of a putative tumor suppressor gene on chromosome 4 in mouse lung tumors. Cancer Res (1994) 0.85
Allelic loss of distal chromosome 4 in mouse lung tumors localize a putative tumor suppressor gene to a region homologous with human chromosome 1p36. Oncogene (1995) 0.85
Use of p53 transgenic mice in the development of cancer models for multiple purposes. Exp Lung Res (2000) 0.85
The intronic structure of cancer-related genes regulates susceptibility to cancer. Mol Carcinog (1994) 0.85
Cdkn2a encodes functional variation of p16INK4a but not p19ARF, which confers selection in mouse lung tumorigenesis. Mol Carcinog (1999) 0.84
Chemopreventive effects of the aromatase inhibitor vorozole (R 83842) in the methylnitrosourea-induced mammary cancer model. Carcinogenesis (1998) 0.84
Quality of life among advanced breast cancer patients with and without distant metastasis. Eur J Cancer Care (Engl) (2012) 0.84
Genetic alterations in mouse lung tumors: implications for cancer chemoprevention. J Cell Biochem Suppl (1997) 0.83
Bcl-2 and Bax are differentially expressed in hyperplastic, premalignant, and malignant lesions of mammary carcinogenesis. Cell Growth Differ (2000) 0.83
Cyclin D1 as a proliferative marker regulating retinoblastoma phosphorylation in mouse lung epithelial cells. Cancer Lett (2001) 0.83
Genetic variants cis-regulating Xrn2 expression contribute to the risk of spontaneous lung tumor. Oncogene (2009) 0.83
Chemopreventive efficacy of promising farnesyltransferase inhibitors. Exp Lung Res (2000) 0.83
Effect of green tea on p53 mutation distribution in ultraviolet B radiation-induced mouse skin tumors. Carcinogenesis (1998) 0.83
Prevention of lung cancer progression by bexarotene in mouse models. Oncogene (2006) 0.81
Sequence variation and chromosomal mapping of the murine Cdkn2a tumor suppressor gene. Mamm Genome (1997) 0.81
Molecular evidence of Babesia caballi (Nuttall and Strickland, 1910) parasite transmission from experimentally-infected SCID mice to the ixodid tick, Haemaphysalis longicornis (Neuman, 1901). Vet Parasitol (2001) 0.81
Allele-specific activation and expression of the K-ras gene in hybrid mouse lung tumors induced by chemical carcinogens. Carcinogenesis (1994) 0.80
ras mutations in 2-acetylaminofluorene-induced lung and liver tumors from C3H/HeJ and (C3H x A/J)F1 mice. Cancer Res (1993) 0.80
Single nucleotide polymorphism (SNP) analysis of mouse pulmonary adenoma susceptibility loci 1-4 for identification of candidate genes. J Med Genet (2003) 0.79
Altered gene expression profile in chemically induced rat mammary adenocarcinomas and its modulation by an aromatase inhibitor. Oncogene (2001) 0.78
Protooncogene activation in spontaneously occurring and chemically induced rodent and human lung tumors. Prog Clin Biol Res (1992) 0.78
Chemopreventive effect of perillyl alcohol on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced tumorigenesis in (C3H/HeJ X A/J)F1 mouse lung. J Cell Biochem Suppl (1997) 0.78
Tissue-specific expression of the K-ras allele from the A/J parent in (A/J x TSG-p53) F1 mice. Gene (1997) 0.78
Effect of early vs. late administration of 4-hydroxyphenylretinamide (4-HPR) on N-methyl-N-nitrosourea (MNU)-induced mammary tumorigenesis. J Cell Biochem Suppl (1997) 0.78
Decreased expression of the adenomatous polyposis coli (Apc) and mutated in colorectal cancer (Mcc) genes in mouse lung neoplasia. Mol Carcinog (1998) 0.78
Chromosome 3p tumor-suppressor gene alterations in cervical carcinomas. Mol Carcinog (2001) 0.78
Smad4 (homolog of human DPC4) and Smad2 (homolog of human JV18-1): candidates for murine lung tumor resistance and suppressor genes. Carcinogenesis (1997) 0.78
Pharmacokinetic and pharmacodynamic consequences of inhibition of terazosin metabolism via CYP3A1 and/or 3A2 by DA-8159, an erectogenic, in rats. Br J Pharmacol (2007) 0.78
Expression of cell cycle proteins in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumors. Exp Lung Res (1998) 0.78
Effect of farnesyltransferase inhibitor FTI-276 on established lung adenomas from A/J mice induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis (2000) 0.78
Detection of genomic alterations in human cervical cancer by two-dimensional gel electrophoresis. J Cell Biochem Suppl (1996) 0.77
Loss of heterozygosity on chromosomes 1, 11, 12, and 14 in hybrid mouse lung adenocarcinomas. Mol Carcinog (1996) 0.77
Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice. Cancer Res (1991) 0.76
Brief communication, P53 accumulation in N-methyl-N-nitrosourea-induced rat mammary tumors. Toxicol Pathol (1996) 0.76
Small molecule antagonists of the bradykinin B1 receptor. Immunopharmacology (1999) 0.76
Characteristic features of the adenomatoid odontogenic tumour on cone beam CT. Dentomaxillofac Radiol (2014) 0.75
B region variant of the estrogen receptor gene. Nucleic Acids Res (1992) 0.75
Diamondback Moth (Lepidoptera: Plutellidae) Exhibits Oviposition and Larval Feeding Preferences Among Crops, Wild plants, and Ornamentals as Host Plants. J Econ Entomol (2016) 0.75
Ki-ras mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-initiated and butylated hydroxytoluene-promoted lung tumors in A/J mice. Mol Carcinog (1994) 0.75
Detection of differentially expressed genes in methylnitrosourea-induced rat mammary adenocarcinomas. J Cell Biochem Suppl (1997) 0.75
Detection of genetic alterations in mouse lung adenocarcinomas by two-dimensional gel electrophoresis. Exp Lung Res (2000) 0.75
Detection of differentially expressed genes in mouse lung adenocarcinomas. Exp Lung Res (2001) 0.75
An ergonomic approach to public squatting-type toilet design. Appl Ergon (1998) 0.75
ras mutations in 2-amino-3-methylimidazo-[4,5-f]quinoline-induced tumors in the CDF1 mouse. Mol Carcinog (1993) 0.75
Detection of oncogene mRNA sequences in cultured cells by in situ hybridization. Ann Clin Lab Sci (1987) 0.75
Lung tumor induction in strain A mice with benzotrichloride. Cancer Lett (1986) 0.75
MR findings in isolated oculomotor nerve palsy associated with infectious mononucleosis caused by Epstein-Barr virus infection. J Comput Assist Tomogr (1998) 0.75
The activation of TC10, a Rho small GTPase, contributes to v-Rel-mediated transformation. Oncogene (2006) 0.75
The 5'-flanking region of the E1 alpha form of the murine p16INK4a (MTS1) gene. Gene (1996) 0.75
DNA quantification in cervical intraepithelial neoplasia thick tissue sections by confocal laser scanning microscopy. J Cell Biochem Suppl (1996) 0.75
[The immunosuppressive activities of polysaccharides from Glehnia littoralis (bei sha shen)]. Yao Xue Xue Bao (1986) 0.75
Isometric muscle strength of Chinese young males in Taiwan. Ergonomics (1997) 0.75
Fine mapping and characterization of candidate lung tumor resistance genes for the Par2 locus on mouse chromosome 18. Exp Lung Res (2000) 0.75
Proto-oncogene activation in rodent and human tumors. Adv Exp Med Biol (1991) 0.75
Chromosome mapping and sequence variation of the murine Ras effector gene Nore1. Cytogenet Cell Genet (2001) 0.75
Role and regulation of Rel/NF-kappaB activity in anti-immunoglobulin-induced apoptosis in WEHI-231 B lymphoma cells. Cell Signal (2000) 0.75
[Arthropod diversity in leafy vegetable field and sampling technology]. Ying Yong Sheng Tai Xue Bao (2000) 0.75